Regulatory
Probiotic Strain DE111 Can Now Be Used in Canada Foods without Novel Food Preapproval
May 22nd 2018Health Canada’s letter of no objection means that Deerland Enzymes & Probiotics’ DE111 strain is no longer a Novel Food and can now be sold as a food ingredient without the need for premarket notification.
Cannabis, CBD Should Not Be Schedule I Drugs, Herbal Leaders Urge FDA in Public Comments
May 2nd 2018FDA called for public comments on the international drug scheduling of cannabis and cannabis-related substances in preparation for a meeting of the World Health Organization. In response, herbal experts and industry leaders urged the agency not to classify cannabis substances as Schedule I drugs.
Sports Nutrition's Biggest Regulatory Hurdles: A Quick Q&A with CRN
May 2nd 2018Nutritional Outlook interviewed Duffy MacKay, ND, senior vice president, scientific and regulatory affairs, Council for Responsible Nutrition, about some of the biggest regulatory hurdles and ingredients to watch in the sports nutrition category.
Pomegranate Adulteration and Test Methods Evaluated in New Guidance Document
April 30th 2018The new Laboratory Guidance Document from the nonprofit ABC-AHP-NCNPR Botanical Adulterants Prevention Program (BAPP) examines several common pomegranate adulteration methods, including diluting those juices and extracts with lower-cost fruit juices or adding ellagic acid from non-pomegranate sources, as well as methods for detecting adulteration in pomegranate juices and extracts.
SARMs Control Act Would Strengthen DEA's Power to Enforce Against SARMs in Dietary Supplements
April 25th 2018The SARMs Control Act of 2018 introduced yesterday by Senators Orrin Hatch (R-UT) and Sheldon Whitehouse (D-RI) would add SARMs to the DEA’s list of Schedule III drugs and ensure that SARMs are regulated similarly to anabolic steroids.
Sabinsa Wins Latest Curcumin Patent Infringement Lawsuit
April 24th 2018Sabinsa announced that in April, the United States District Court in New Jersey awarded the company $850,000 in damages, ruling that Olive Lifesciences infringed on Sabinsa’s patent covering novel methods and formulations for producing tetrahydrocurcuminoids.
New Certified for Sport App Vets Sports Supplement Safety
February 6th 2018NSF International said that the newly designed app and website support its Certified for Sport testing program and help athletes and consumers avoid potentially harmful ingredients and banned substances in dietary supplements.
Industry Associations Respond to Meta-Analysis of Omega-3 and Heart Disease Research
February 5th 2018GOED issued a statement to its members affirming several points, including that the meta-analysis, which showed that omega-3 fatty acid supplementation had no significant associations with CHD death, nonfatal myocardial infarction, any coronary heart disease events, or major vascular events, adds little to the current body of evidence surrounding omega-3s and cardiovascular risk factors.